Full-Time
Confirmed live in the last 24 hours
Healthcare technology using AI for patient outcomes
$70k - $100kAnnually
Junior, Mid
Company Historically Provides H1B Sponsorship
Chicago, IL, USA
Hybrid role; expected to work some days in-office.
You match the following Tempus's candidate preferences
Employers are more likely to interview you if you match these preferences:
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.
Company Size
1,001-5,000
Company Stage
IPO
Total Funding
$894.9M
Headquarters
Chicago, Illinois
Founded
2015
Help us improve and share your feedback! Did you find this helpful?
Relocation Assistance
Company Equity
Performance Bonus
Apollon Wealth Management LLC makes new $256,000 Investment in Tempus AI, Inc. (NASDAQ:TEM).
Tempus announced yesterday that it was collaborating with the nonprofit Institute for Follicular Lymphoma Innovation to develop treatment options for patients with the disease.
Currently connected to more than 50% of all oncologists practising in the US, Chicago-based Tempus will work with Artera on an exclusive basis to commercialise the latter's ArteraAI prostate test.
Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation.
What You Should Know:– Tempus AI, a provider of AI-powered precision medicine launches olivia, an innovative personal health concierge app designed to revolutionize how patients manage their health information.– olivia brings together a patient’s health data from various sources, leverages AI to provide actionable insights, and empowers patients to take control of their health journey.Centralizing Health DataOlivia serves as a central hub for all of a patient’s health information. Patients can connect to over 1,000 health systems through electronic health record (EHR) integration, sync data from health devices to track daily metrics, or manually upload health records. This comprehensive data integration allows patients to access a complete and accurate picture of their health history.Actionable Insights Through AIolivia’s AI-enabled capabilities transform raw data into actionable insights. Patients can ask questions about their records, summarize their health information, and receive personalized responses based on their data. For example, a patient can ask, “Summarize my health status,” and olivia will provide a clear, concise summary of their health information.Empowering Patients to Take Control of Their HealthIn addition to centralizing data and providing actionable insights, olivia offers several other features to enhance the patient experience:Smart Profile Summary: olivia synthesizes a patient’s data into an AI-generated smart profile, detailing information such as clinical diagnoses, family history, medications, and care team.olivia synthesizes a patient’s data into an AI-generated smart profile, detailing information such as clinical diagnoses, family history, medications, and care team. AI-enabled Notetaker: olivia provides patients with written transcripts, audio files, and smart summaries of physician appointments, accessible and searchable via the app’s AI interface.olivia provides patients with written transcripts, audio files, and smart summaries of physician appointments, accessible and searchable via the app’s AI interface